Despite high heterogeneity, the results provided imaging evidencefor the atherosclerotic effects of Lp(a), supporting its inclusion in the riskassessment system for primary prevention of cardiovascular disease (CVD) andproviding an evidence-based basis for formulating early intervention strategiesfor high-risk populations [37]. This evidence concerns the gene LPA and cardiovascular disorder.